We examined the mechanism by which estrogen regulates telomerase activity in Caov-3 human ovarian cancer cell lines, which express ER, to determine whether the regulation affects the expression and/or phosphorylation of the telomerase catalytic subunit (hTERT). 17b-Estradiol (E 2 ) induced telomerase activity and hTERT expression. Transient expression assays using luciferase reporter plasmids containing various fragments of hTERT promoter showed that the estrogen-responsive element appeared to be partially responsible for the E 2 -induced activation of the hTERT promoter. Either pretreatment with a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, or transfection with a dominantnegative Akt attenuated the E 2 -induced activation of the hTERT promoter. In addition, estrogen induced the phosphorylation of IjB inhibitor protein via the Akt cascade, and cotransfection with a dominant-negative subunit of NFjB attenuated the response of the ERE-deleted hTERT promoter to E 2 . Moreover, E 2 induced the phosphorylation of hTERT, the association of 14-3-3 protein and NFjB with hTERT, and nuclear accumulation of hTERT in an Akt-dependent manner. These results indicate that E 2 induces telomerase activity not only by transcriptional regulation of hTERT via an ERE-dependent mechanism and a PI3K/Akt/NFjB cascade, but also by post-transcriptional regulation via Akt-dependent phosphorylation of hTERT. Thus, the phosphorylation of Akt is a key event in the induction of telomerase activity by E 2 in human ovarian cancer cells.
Introduction
It was recently reported that estrogen replacement therapy (ERT) induces ovarian cancer (Lacey et al., 2002) . However, the mechanism by which estrogen induces carcinogenesis of ovarian tissue remains elusive. Many alterations occur during multistep ovarian carcinogenesis, including interaction of the tumor cells with peptide growth factors, activation of protooncogenes, and loss of tumor-suppressor genes (Chow et al., 1996) . A relationship between telomerase expression and ovarian carcinogenesis was reported (Murakami et al., 1997) . In addition, it was reported that estrogen activates telomerase in MCF-7 cells (Kyo et al., 1999c) , endometrial cancer cells (Wang et al., 2000) , and human ovary epithelium cells (Misiti et al., 2000) . However, the mechanism by which estrogen induces telomerase activity in ovarian tissue remains elusive.
Telomerase is a cellular reverse transcriptase that catalyses the synthesis and extension of telomeric DNA Blackburn, 1985, 1989) . This enzyme is specifically activated in most malignant tumors but is usually inactive in normal somatic cells, with the result that telomeres are progressively shortened with cell division (Kim et al., 1994; Shay and Bacchetti, 1997) . Cells require a mechanism to maintain telomere stability in order to overcome replicative senescence, and telomerase activation may therefore be a rate-limiting or critical step in cellular immortality and oncogenesis (Harley and Villeponteau, 1995) . Although the RNA subunit (hTR) of the human telomerase complex is constitutively expressed in both tumor and normal somatic tissues, expression of the catalytic subunit (hTERT) correlates with telomerase activity during cellular differentiation and neoplastic transformation Kyo et al., 1999a, b) . A strong correlation is observed between hTERT mRNA expression and telomerase activity in a variety of epithelial cancers, including cervical (Nakano et al., 1998) , breast, colon (Boldrini et al., 2002) , ovarian (Park et al., 1999) , and renal carcinomas.
On the other hand, telomerase activity can also be regulated by post-translational modifications of the enzyme. One possible mechanism for the post-translational modifications of telomerase is the interaction of hTERT with accessory proteins. Recently, it was reported that 14-3-3 proteins, which have been proposed to be important in controlling intracellular signaling cascades by associating with a number of different signaling proteins (Moorhead et al., 1996) and to work as molecular chaperones or to regulate intracellular localization of their binding partners (Yang et al., 1999) , are post-translational modifiers of telomerase that function by controlling the intracellular localization of hTERT (Seimiya et al., 2000) .
There is abundant evidence that the regulation of telomerase in mammalian cells is multifactorial. It was reported that the region surrounding Ser-824 in hTERT conforms to a consensus sequence for phosphorylation by Akt, and that Akt kinase enhances human telomerase activity through phosphorylation of hTERT (Kang et al., 1999) . In addition, it was reported that proatherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism (Breitschopf et al., 2001) . We previously reported that both estrogen (Hisamoto et al., 2001b) and raloxifene (Hisamoto et al., 2001a) induce eNOS activation via an Akt cascade. In addition, it was reported that an Akt cascade mediates the estrogen-induced S-phase entry and cyclin D1 promoter activity in MCF-7 cells (Castoria et al., 2001 ). Thus, it appeared possible that estrogen enhances human telomerase activity through an Akt cascade. Another possible mechanism for posttranslational modulation of telomerase activity is via the interaction of hTERT with accessory proteins. Recently, it was reported that 14-3-3 proteins (Yang et al., 1999; Seimiya et al., 2000) and NFkB (Akiyama et al., 2003) are post-translational modifiers of telomerase that function by controlling the intracellular localization of hTERT.
The hTERT promoter contains the imperfect palindromic estrogen-responsive element, and it was reported that estrogen activates telomerase via direct and indirect effects on hTERT in MCF-7 cells (Kyo et al., 1999c) . However, the mechanism of the indirect effects remains elusive. It was reported that the hTERT promoter contains two putative NFkB-binding motifs (Yin et al., 2000) , and that IGF-1 and IL-6 activate PI3K/Akt/NFkB in a human multiple myeloma cell line (Akiyama et al., 2002) . Thus, it is possible that estrogen enhances transcriptional regulation of hTERT by a PI3K/Akt/ NFkB cascade.
These findings led us to examine whether a PI3K/ Akt/NFkB cascade is involved in the estrogeninduced transcriptional regulation of hTERT and whether a PI3K/Akt cascade is also involved in both estrogen-induced phosphorylation of hTERT and interaction of hTERT with 14-3-3 proteins and NFkB, leading to nuclear transport of hTERT.
Results

E 2 induces telomerase activity and hTERT expression
To examine the effects of estrogen on telomerase activity, Caov-3 human ovarian cancer cells were treated with 10 nM 17b-estradiol (E 2 ) for the indicated times. Telomerase activity was detectably induced by 10 nM E 2 at 6 h, reached a plateau at 24 h ( Figure 1a , left panel), and declined thereafter (data not shown). ICI 182,780 (a highly selective ER antagonist) attenuated the E 2 -induced telomerase activity (Figure 1a , right panel), indicating that E 2 induces telomerase activity via an ER-dependent mechanism.
Semiquantitative RT-PCR assays were performed to examine whether activation of telomerase by estrogen (a) Caov-3 cells were treated with 10 nM E 2 for different times as indicated (left panel) or for 24 h with or without pretreatment with 1 mM ICI182780 for 15 min (right panel), and subjected to quantitative stretch PCR assays to assess telomerase activity. A representative example of an experiment that was repeated three times is shown. (b) RT-PCR assays to examine the effects of E 2 on the expression of hTERT. Caov-3 cells were incubated with or without 10 nM E 2 in the absence or presence of pretreatment with 1 mM ICI182780 for 15 min. After 24 h, RNA was extracted and RT-PCR assays were performed to detect hTERT mRNA. A representative example of an experiment that was repeated three times is shown. (c) Caov-3 cells were transfected with various luciferase reporter plasmids containing full-length (À3328), 5 0 -deleted hTERT promoters (À82, À1175, and À2000), or the untranslated downstream sequences ( þ 19) and incubated with or without 10 nM E 2 . After 24 h, the cells were collected and luciferase assays were performed. The transcriptional activity of each reporter plasmid was normalized with respect to that of vehicletreated cells transfected with pGL þ 19 taken as 1.0. The values shown represent the mean 7s.e. from at least three separate experiments. Significant differences are indicated by asterisks. **, Po0.01 (d) Caov-3 cells were transfected with pGL3-ERE-P containing head-to-tail tetramers of ERE in hTERT promoter or enhancer-less pGL3-promoter (pGL3), and incubated with or without 10 nM E 2 . After 24 h, cell pellets were collected and luciferase assays were performed. The transcriptional activity of each reporter plasmid was normalized with respect to that of vehicle-treated cells transfected with pGL3 taken as 1.0. The values shown represent the mean 7s.e. from at least three separate experiments. Significant differences are indicated by asterisks. **, Po0.01
Akt-dependent estrogen-induced telomerase activation A Kimura et al was due to upregulation of the expression of hTERT. Treatment of Caov-3 cells with 10 nM E 2 for 24 h led to upregulation of hTERT mRNA, and ICI 182,780 attenuated the E 2 -induced upregulation of hTERT mRNA (Figure 1b ), indicating that E 2 induces hTERT expression via an ER-dependent mechanism.
To examine the effect of estrogen on the transcriptional activity of the hTERT promoter, luciferase assays in which hTERT-promoter reporter plasmids were transfected were performed. It has been reported that an imperfect palindromic ERE is located at À2677. Luciferase reporter plasmids containing the full-length hTERT 5 0 regulatory region (pGL3-3328), a deletion mutant of the imperfect palindromic ERE (pGL3-2000, pGL3-1175, and pGL-82) , or the untranslated downstream sequences (pGL3 þ 19) were transfected into Caov-3 cells. Whereas E 2 activated the transcriptional activity of pGL3-3328 up to 2.5-fold (Figure 1c ), the estrogen responsiveness using pGL3-2000 was significantly weaker than that using the pGL3-3328 promoter, suggesting that the ERE at least affects transcription in the context of the hTERT promoter. Moreover, to examine whether the ERE at À2677 is involved in the E 2 -induced hTERT promoter activity, this putative ERE was cloned upstream of the SV40 promoter in a luciferase reporter plasmid (pGL3-ERE-promoter) and used for transfection. E 2 treatment caused 1.9-fold transcriptional activation of the transfected plasmid ( Figure 1d ). Although E 2 had no effect on the transcriptional activity of pGL3 þ 19, it did activate the transcriptional activity of pGL3-1175 and À2000 to some extent. These results suggest that the ERE at À2677 is partially responsible for the E 2 -induced activation of the hTERT promoter.
Akt-dependent E 2 -induced hTERT expression
We first examined whether E 2 induces Akt phosphorylation in Caov-3 cells. The cells were treated with E 2 for various times and then used to prepare lysates that were subjected to Western blotting with anti-phospho-Akt antibody or ÀAkt antibody. Although E 2 did not affect the expression of Akt (Figure 2a (Figure 2b ). Although highest responses were detectable 30 min after E 2 exposure, these responses were still detectable 24 h after E 2 exposure. We then examined the mechanism by which E 2 induces Akt phosphorylation. Although the expression of Akt was not affected by ICI (an ER antagonist), PP2 (a Src inhibitor), or LY294002 (a PI3K inhibitor) (Figure 2c , lower panel), E 2 -induced Akt phosphorylation was attenuated by these agents (Figure 2c , middle and upper panel), suggesting that E 2 induces Akt phosphorylation through ER, Src, and PI3K. To examine the functional relevance for E 2 -induced Akt phosphorylation, the effect of estrogen on the proliferation of Caov-3 and the effect of LY294002 on the estrogen's effect of the proliferation were examined. E 2 (10 nM) was added daily with or without LY294002, followed by analysis of cell proliferation by MTS assay. E 2 significantly stimulated the cell proliferation and the treatment with LY294002 significantly inhibited the E 2 -induced cell proliferation ( Figure 2d ). Next, we examined whether E 2 induces hTERT expression via an Akt cascade. The effects of LY294002 on E 2 -induced hTERT expression ( Figure 3a ) and promoter activity ( Figure 3b ) were examined. Although neither E 2 nor LY294002 had any effect on GAPDH expression 
NFkB is a nuclear target of E 2 -induced hTERT expression via the Akt cascade
It has been reported that IGF-1 and IL-6 activate PI3K/Akt/NFkB in a human multiple myeloma cell line (Akiyama et al., 2002) , and that the hTERT promoter contains two putative NFkB-binding motifs at À749 and À654 (Yin et al., 2000) . Therefore, we examined whether NFkB is a nuclear target of E 2 -induced hTERT expression via the Akt cascade. NFkB is regulated through its association with an inhibitory cofactor, IkB, which sequesters NFkB in the cytoplasm. Phosphorylation of IkB by upstream kinases promotes its degradation, allowing NFkB to translocate to the nucleus and induce target genes (Ozes et al., 1999; Romashkova and Makarov, 1999) . We first examined whether E 2 induces the phosphorylation of IkB (Figure 5a ). Cells were treated with E 2 for 30 min and used to prepare lysates that were analysed by Western blotting with anti-phosphoIkB antibody. Although the expression of Akt was not RT-PCR assays to examine the effects of PI3K inhibitor on E 2 -induced activation of hTERT expression. Caov-3 cells were incubated with or without 10 nM E 2 in the absence or presence of 10 mM LY294002. After 24 h, RNA was extracted and RT-PCR assays were performed to detect hTERT mRNA. A representative example of an experiment that was repeated three times is shown. (b) Caov-3 cells were transfected with luciferase reporter plasmid containing full length (À3328) and incubated with or without 10 nM E 2 in the absence or presence of 10 mM LY294002. After 24 h, cell pellets were collected and used to prepare lysates that were subjected to luciferase assays. The transcriptional activity was normalized with respect to that in cells treated with vehicle taken as 1.0. Values shown represent the mean 7s.e. from at least three separate experiments. Significant differences are indicated by asterisks. **, Po0.01 Figure 4 Expression of dominant-negative Akt attenuates E 2 -induced hTERT expression. (a) The effect of expressed Akt on the activation of Akt was examined. Caov-3 cells were transfected with pcDNA, pcDNA-CA-Akt, or pcDNA-DN-Akt. Then the cells were incubated with or without 10 nM E 2 . Lysates were subsequently immunoprecipitated with immobilized anti-Akt antibody and the kinase reaction was carried out in the presence of cold ATP and GSK-3a fusion protein, as described in 'Materials and methods'. A representative example of an experiment that was repeated three times is shown. (b) RT-PCR assays to examine the role of the Akt cascade in E 2 -induced expression of hTERT. Caov-3 cells were transfected with pcDNA, pcDNA-CA-Akt, or pcDNA-DN-Akt. Then the cells were incubated with or without 10 nM E 2 . After 24 h, RNA was extracted and subjected to RT-PCR assays to detect hTERT mRNA. A representative example of an experiment that was repeated three times is shown. (c) Caov-3 cells were cotransfected with luciferase reporter plasmids containing fulllength hTERT promoters and pcDNA, pcDNA-CA-Akt, or pcDNA-DN-Akt. After transfection, cells were incubated with or without 10 nM E 2 . After 24 h, cell pellets were collected and used to prepare lysates that were subjected to luciferase assays. The transcriptional activity of each plasmid was normalized with respect to that of vehicle-treated cells transfected with pcDNA taken as 1.0. Values shown represent the mean 7s.e. from at least three separate experiments. Significant differences are indicated by asterisks. **, Po0.01 changed (Figure 5a , bottom panel), E 2 induced the phosphorylation of IkB, and pretreatment with LY294002 clearly attenuated the E 2 -induced phosphorylation of IkB (Figure 5a , top and middle panels), suggesting that E 2 induces the activation of NFkB through phosphorylation of IkB in a PI3K-dependent manner.
We next examined whether NFkB is involved in the induction of hTERT promoter activity by E 2 . To confirm the role of NFkB in the E 2 -induced activation of hTERT expression, we treated cells with BAY 11-7082, a known pharmacological inhibitor of IkBa phosphorylation (Pierce et al., 1997) . In the presence of BAY 11-7082, the E 2 -induced transactivation of pGL3-2000, a deletion mutant of the imperfect palindromic ERE, was attenuated by about 40% (Po0.01) (Figure 5b ). The best-characterized species of NFkB dimer is the p50/p65 heterodimer (Chen et al., 1998) . A previous report demonstrated that the nuclear localization signal (NLS) polypeptide of p50 is required for its translocation to nucleus (Baeuerle and Baltimore, 1996) , and that p50DNLS lacking the NLS domain inhibits the nucleocytoplasmic shuttling of NFkB dimers. Therefore, we examined the effect of p50DNLS on the induction of hTERT promoter activity by E 2 . Cotransfection of p50DNLS significantly attenuated the E 2 -induced transactivation of pGL3-2000 compared to the induction in cells expressing wild-type p50 (Figure 5c ).
E 2 induces the phosphorylation of hTERT in an Akt-dependent manner
Telomerase activity may also be regulated by posttranslational modifications of the enzyme. It has been reported that the region surrounding Ser-824 in hTERT conforms to a consensus sequence for phosphorylation by Akt, and that Akt kinase enhances human telomerase activity through phosphorylation of hTERT (Kang et al., 1999) . Therefore, we examined whether E 2 induces the phosphorylation of hTERT in an Akt-dependent manner. Caov-3 (Figure 6a Role of PI3K/Akt/NFkB cascade in E 2 -induced activation of hTERT expression. (a) Caov-3 cells were incubated with or without 10 mM LY249002 for 15 min prior to activation with 10 nM E 2 for 30 min, and then harvested and used to prepare cell lysates that were subjected to SDS-PAGE, transferred to a nitrocellulose membrane, and blotted with anti-phospho-IkB (middle panel) or anti-Akt (bottom panel) antibodies. Relative densitometric units of phospho-IkB bands are shown in the top panel, with the density of the control bands set arbitrarily at 1.0. Values shown represent the mean 7s.e. from at least three separate experiments. Significant differences are indicated by asterisks. **, Po0.01 (b) Caov-3 cells were transfected with luciferase reporter plasmids containing 5 0 -deleted hTERT promoter (pGL3-2000). After transfection, cells were incubated with or without 5 mM BAY 11-7082 for 1 h prior to activation with or without 10 nM E 2 . After 24 h, cell pellets were collected and used to prepare lysates that were subjected to luciferase assays. The transcriptional activity was normalized with respect to that in cells treated with vehicle taken as 1.0. Values shown represent the mean 7s.e. from at least three separate experiments. Significant differences are indicated by asterisks. **, Po0.01. (c) Caov-3 cells were cotransfected with luciferase reporter plasmids containing 5 0 -deleted hTERT promoter (pGL3-2000) and pCR-FLAG-p50 or pCR-FLAG-p50DNLS. After transfection, the cells were incubated with or without 10 nM E 2 . After 24 h, cell pellets were collected and used to prepare lysates that were subjected to luciferase assays. The transcriptional activity of each plasmid was normalized with respect to that of vehicle-treated cells transfected with p50 taken as 1.0. Values shown represent the mean 7s.e. from at least three separate experiments. Significant differences are indicated by asterisks. **, Po0.01
Figure 6 E 2 induces the phosphorylation of hTERT in an Aktdependent manner. For detection of phosphorylated hTERT, Caov-3 cells were incubated with 10 nM E 2 for various times (a), or MCF-7 cells were incubated with 10 nM E 2 for 30 min (b), or Caov-3 cells were incubated with 10 nM E 2 for 30 min in the absence or presence of pretreatment with 1 mM ICI 182780 for 15 min or 10 mM LY249002 for 15 min (c) before the cells were harvested and lysed. The lysates were subjected to immunoprecipitation with antihTERT antibody. The immunoprecipitates were subjected to SDS-PAGE, and the separated proteins were transferred to a nitrocellulose membrane and blotted with anti-phospho-Akt substrate (upper panel) or anti-hTERT (lower panel) antibodies. A representative example of an experiment that was repeated three times is shown Akt-dependent estrogen-induced telomerase activation A Kimura et al attenuated the E 2 -induced hTERT phosphorylation in Caov-3 (Figure 6c , upper panel) and in MCF-7 cells (data not shown). The anti-hTERT Western blot analysis shows equal precipitation of hTERT protein ( Figure 6 , lower panel). These data suggest that E 2 induces the phosphorylation of hTERT in a manner mediated by ER via PI3K/Akt in both Caov-3 and MCF-7 cells.
E 2 induces the association of 14-3-3 protein and NFkB with hTERT
One possible mechanism for the post-translational modification of telomerase is via the interaction of hTERT with 14-3-3 proteins (Seimiya et al., 2000) . Therefore, we examined whether E 2 induces the association of 14-3-3 protein with hTERT ( Figure 7 ). Cells were transfected with pCR3-hTERT-HA and then treated with E 2 for 30 min and used to prepare cell lysates that were incubated with GST-14-3-3 fusion protein immobilized on glutathione-Sepharose. Exogenous hTERT bound to the beads was detected by anti-HA Western blot analysis. E 2 induced the association of overexpressed hTERT with 14-3-3 protein, and pretreatment of the cells with LY294002 attenuated the E 2 -induced association of exogenous hTERT with 14-3-3 protein (Figure 7a) . Moreover, to examine whether endogenously expressed hTERT also interacts with 14-3-3 protein via E 2 , cells were treated with E 2 for 30 min and used to prepare cell lysates that were incubated with GST-14-3-3 fusion protein immobilized on glutathione-Sepharose. E 2 also induced the association of endogenously expressed hTERT with 14-3-3 protein, and pretreatment of the cells with LY294002 or ICI 182,780 attenuated the E 2 -induced association of endogenous hTERT with 14-3-3 protein (Figure 7b ). These results suggest that E 2 induced the association of hTERT with 14-3-3 protein in a manner mediated by ER via PI3K/Akt.
It was reported that NFkB is a post-translational modifier of telomerase that functions by controlling the intracellular localization of hTERT (Akiyama et al., 2003) . Therefore, we examined whether E 2 induces the association of NFkB p65 with hTERT. Cells were treated with E 2 for 30 min and used to prepare cell lysates that were immunoprecipitated with anti-hTERT antibody or anti-HA antibody (nonrelevant control antibody) and then subjected to Western blotting with anti-NFkB p65 (Figure 8 
E 2 induces nuclear accumulation of hTERT
We next examined whether E 2 induces nuclear accumulation of hTERT in both Caov-3 and MCF-7 cells. Cells were transfected with pCR3-hTERT-HA and subjected to indirect immunofluorescence staining. Expression of hTERT-HA was detected by confocal microscopy. hTERT-expressing cells were evaluated for cytoplasmic (C), nuclear-cytoplasmic (N þ C), and nuclear (N) fluorescence (Figure 9a ). E 2 induced nuclear accumulation of hTERT from 30 min to 24 h in Caov-3 cells (Figure 9b) , as we have also demonstrated in MCF-7 cells (Kawagoe et al., 2003) . Most of the TERT protein was also localized in the cytoplasm under normal serum conditions (data not shown). Pretreatment with LY294002, ICI 182,780, or BAY11-7082 attenuated the E 2 -induced nuclear accumulation of hTERT in both Caov-3 (Figure 9c , left panel) and MCF-7 (Figure 9c , right panel) (Kawagoe et al., 2003) cells. These data suggest that E 2 -induced nuclear accumulation of hTERT is mediated by ER via a PI3K/Akt/NFkB cascade in both Caov-3 and MCF-7 cells.
Figure 7 E 2 induces the association of 14-3-3y protein with hTERT. In vitro binding of hTERT with 14-3-3y in response to E 2 in Caov-3. (a) Caov-3 cells were transfected with pCR3-hTERT-HA (hTERT-HA) or pCR3 vector. After transfection, cells were incubated with or without 10 mM LY249002 for 15 min prior to activation with 10 nM E 2 for 30 min. The GST 14-3-3y fusion protein was immobilized on glutathione-Sepharose and incubated with the cell lysates. After extensive washing, the bound fraction was analysed by Western blotting with anti-HA antibody (upper panel). Equal loading of each GST fusion protein was confirmed by Coomassie Blue staining of the SDS-PAGE gel (data not shown). The proteins in the cell lysates were also separated by SDS-PAGE, transferred to a nitrocellulose membrane, and blotted with anti-HA (middle panel) and anti-14-3-3y (lower panel) antibodies. A representative example of an experiment that was repeated three times is shown. (b) Caov-3 cells were incubated with 10 mM LY249002 for 15 min or 1 mM ICI 182780 for 15 min prior to activation with 10 nM E 2 for 30 min. The GST 14-3-3y fusion protein was immobilized on glutathione-Sepharose and incubated with the cell lysates. After extensive washing, the bound fraction was analysed by Western blotting with anti-hTERT antibody (upper panel). The proteins in the cell lysates were also separated by SDS-PAGE, transferred to a nitrocellulose membrane, and blotted with anti-Akt antibody (lower panel). A representative example of an experiment that was repeated three times is shown
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Discussion
There is abundant evidence that the mechanism of the regulation of telomerase is multifactorial in mammalian cells, and involves telomerase gene expression Nakano et al., 1998; Takakura et al., 1998; Cong et al., 1999; Kyo et al., 1999a, b; Park et al., 1999; Wick et al., 1999; Boldrini et al., 2002) , post-translational protein-protein interactions (Holt et al., 1999; Seimiya et al., 2000; Akalin et al., 2001) , and protein phosphorylation (Li et al., 1997 (Li et al., , 1998 Kang et al., 1999; Liu et al., 2001; Akiyama et al., 2003) . Several protooncogenes and tumor-suppressor genes have been inferred to play either direct or indirect roles in the regulation of telomerase activity; these include genes for c-Myc, Bcl-2, p21WAF1, Rb, p53, PKC, Akt, and protein phosphatase 2A (Liu, 1999) . The hTERT promoter contains an imperfect palindromic estrogen-responsive element, and the transient expression assays we performed here using luciferase reporter plasmids containing various fragments of the hTERT promoter showed that this imperfect palindromic estrogen-responsive element is responsible for transcriptional activation by ligand-activated ER (Figure 1) , as reported previously (Kyo et al., 1999c; Misiti et al., 2000) . We also found that the PI3K/Akt/ NFkB cascade is responsible for the estrogen-induced transcriptional activation of hTERT (Figures 3-5) , as shown previously in the case of cytokine-induced telomerase activity (Akiyama et al., 2002) . Although the hTERT promoter contains two putative NFkBbinding motifs, no DNA binding was observed (Yin et al., 2000) . Therefore, NFkB may regulate hTERT expression via c-Myc because c-Myc is a downstream target of NFkB (Bourgarel-Rey et al., 2001 ) that upregulates hTERT transcription. It was reported previously that estrogen activates c-Myc expression, and that E-boxes in the hTERT promoter that bind cMyc/Max play additional roles in estrogen-induced transactivation of hTERT (Kyo et al., 1999c) . Thus, estrogen induces transcriptional activation of hTERT via both an ERE-dependent mechanism and the PI3K/ Akt/NFkB cascade in human ovarian cancer cells.
We also determined the mechanism of the posttranscriptional induction of telomerase activity. Phosphorylation of hTERT protein is one mechanism of hTERT activation. Telomerase activity in human breast cancer cells is markedly inhibited by treatment with protein phosphatase 2A (Li et al., 1997) . Some protein kinases, such as Akt kinase and protein kinase C, have been reported to mediate the phosphorylation of hTERT protein, leading to telomerase activation (Li et al., 1998; Kang et al., 1999) . In the present study, estrogen induced the phosphorylation of hTERT via a PI3K/Akt cascade in both Caov-3 and MCF-7 cells (Figure 6 ), as in the case of cytokine-induced telomerase activity (Akiyama et al., 2002) . Moreover, a potentially interesting mechanism of telomerase regulation through hTERT phosphorylation linked to nuclear localization of the enzyme has recently been reported (Liu et al., 2001) , suggesting that nuclear translocation of telomerase from a presumably nonfunctional cytosolic location to a physiologically relevant nuclear compartment may be one mechanism of the regulation of telomerase function in cells. In the present report, we demonstrated that LY294002, which inhibits the estrogen-induced phosphorylation of both Akt (Figure 2c ) and hTERT (Figure 6c) , also inhibits the estrogen-induced nuclear translocation of hTERT ( Figure 9 ). Thus, phosphorylation of hTERT seems to be necessary for the initial step of the estrogen-induced nuclear translocation of hTERT. These data provide evidence for novel control mechanisms of estrogen-induced telomerase activity, independent of the hTERT protein level.
Do the transcriptional and the post-translational regulation of TERT by the Akt cascade occur in parallel? Phosphorylation of Akt (Figure 2a ) and hTERT ( Figure 6a ) were still detectable 24 h after E 2 exposure. In addition, LY294002 inhibits both the estrogen-induced hTERT expression at 24 h (Figure 3 ) and the estrogen-induced nuclear translocation of hTERT that was still detected at 24 h (Figure 9c ). Thus, our data suggest that the transcriptional and the posttranslational regulation of TERT by the Akt cascade occur in parallel, and Akt phosphorylation stimulated by estrogen is a common initial step for transcriptional and post-translational regulation of hTERT.
What is the functional relevance for hTERT-induced phosphorylation by Akt? Previous report demonstrated that the inhibition of telomerase acitivity with antisense hTERT in human thyroid cancer cells (Teng et al., 2003) or human bladder cancer cells (Kraemer et al., 2003) inhibit tumor growth. In this experiments, LY294002 inhibits the estrogen-induced cell proliferation in Caov-3 cells (Figure 2d ), suggesting that Akt cascade is involved in estrogen-induced cell proliferation. Since Akt may be a common initial step for transcriptional and posttranslational regulation, hTERT-induced phosphorylation by Akt might be also necessary for the initial step for increase in proliferation.
The Hsp90 chaperone complex, which includes Hsp90, Hsp70, and p23, is functionally associated with telomerase (Holt et al., 1999) . Expression of this chaperone complex is upregulated during malignant transformation or in advanced cancers compared to surrounding noncancerous tissues (Akalin et al., 2001) , suggesting that upregulation of the chaperone complex may play a role in the telomerase activation observed in cancer cells. In addition, it was recently reported that 14-3-3 signaling proteins, which work as molecular chaperones or regulate the intracellular localization of their binding partners, are hTERTbinding partners, and that 14-3-3 enhances the nuclear localization of hTERT (Seimiya et al., 2000) . It has also been reported that NFkB is a post-translational modifier of telomerase that functions by controlling the intracellular localization of hTERT (Akiyama et al., 2003) . In this report, we showed that estrogen induced the association of hTERT with 14-3-3 proteins (Figure 7 ) and NFkB p65 (Figure 8 ), suggesting that both 14-3-3 proteins and NFkB p65 might act as hTERT-binding partners when estrogen induces nuclear accumulation of hTERT.
We have recently observed that estrogen activates the PI3K/Akt cascade in endothelial cells via ERa through a nongenomic mechanism, and that the stimulation of this cascade leads to an increase of nitric oxide synthesis (Hisamoto et al., 2001b) . Although it remains unclear what molecules may function upstream of the PI3K/Akt cascade, it was reported that ERa interacts directly with the Src-SH2 domain (Migliaccio et al., 2000) and p85 (Simoncini et al., 2000) . In addition, it was reported that a Src inhibitor prevents hormonal stimulation of the PI3K and Akt activities in MCF-7 cells, and that hormone stimulation rapidly triggers the association of ERa with Src and p85, indicating that PI3K in concert with Src promotes the S-phase entry of estrogenstimulated MCF-7 cells (Castoria et al., 2001) . In this study, we showed that estrogen-induced Akt phosphorylation is mediated by ER, Src, and PI3K (Figure 2b ), suggesting the existence of crosstalk between Src and PI3K regulated by estrogen.
It was reported that JNK, but not Akt, can induce telomerase activity via transcriptional activation of hTERT in ovarian surface epithelial cells (Alfonso-De Matte et al., 2002) . The finding that there is an inverse correlation between telomerase activity and Akt activation indicates a lack of involvement of Akt in estrogeninduced transcriptional activation of hTERT. However, transfection of dominant-negative Akt apparently attenuated the estrogen-induced transcriptional activation of hTERT (Figure 4) . Transfection of dominantnegative JNK slightly attenuated the estrogen-induced transcriptional activation of hTERT (data not shown). Although we cannot exclude the possibility that JNK is also a downstream target of PI3K, Akt appears to be a major downstream target of PI3K.
It has been reported that estrogen induces the ERK cascade in MCF-7 (Migliaccio et al., 1996) and vascular endothelial cells (Hisamoto et al., 2001a, b) . Although it remains unclear whether the ERK cascade is involved in estrogen-induced telomerase activity, the ERK cascade is known to be involved in the induction of telomerase activity by tamoxifen in Ishikawa cells and by progesterone in MCF-7 cells (Wang et al., 2000) . EGF activates telomerase through the activation of TERT transcription via Ras/MEK/ERK/Ets in human vulvar cancer A-431 cells . Two ETS motifs are located in the core promoter of hTERT. The estrogen-induced transcriptional activation of hTERT was detected in the pGL3-181 promoter, which contains the core promoter (data not shown). Thus, there is still a possibility that the ERK cascade is involved in the induction of telomerase activity by estrogen.
In summary, this study is the first to indicate that E 2 induces telomerase activity not only by transcriptional regulation of hTERT via an ERE-dependent mechanism and a PI3K/Akt/NFkB cascade, but also by posttranscriptional regulation via Akt-dependent phosphorylation of hTERT.
Materials and methods
Materials
17b-Estradiol was purchased from Sigma (St Louis, MO, USA). ICI182780 was obtained from TOCRIS (Ballwin, MO, USA). PP2 and LY294002 were purchased from Calbiochem. The anti-phospho-Akt (Ser473), phospho-Akt substrate, Akt, and phospho-IkBa (Ser32) antibodies, and the Akt kinase assay kit, including GSK-3 fusion protein and a phosphospecific GSK-3a/b antibody, were obtained from Cell Signaling Technology (Beverly, MA, USA). The anti-HA, hTERT, 14-3-3y and NFkB p65 antibodies were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). The NFkB inhibitor BAY 11-7082 was purchased from Alexis Biochemicals (San Diego, CA, USA). The Cell Titer 96-cell proliferation assay kit was obtained from Promega (Madison, WI, USA).
Cell culture
Human ovarian papillary adenocarcinoma cell line (Caov-3) cells and MCF-7 human breast cancer cells were obtained from the American Type Culture Collection. The cells were grown in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum and 100 U/ml penicillin G sodium, and 100 mg/ml streptomycin sulfate in the presence of 5% CO 2 at 371C. For estrogen induction assays, cells were cultured in phenol redfree DMEM containing 10% dextran-coated, charcoal-treated fetal calf serum for 48 h, and then incubated with E 2 , ICI182780, PP2, or LY294002 alone or in combination.
Constructs pCR3 vector, pCR3-hTERT-HA (full-length hTERT with the HA epitope), and GST-14-3-3y constructs were kind gifts from Dr Takashi Tsuruo (Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan) (Seimiya et al., 2000) . pCR-FLAG-p50 (full-length human p50 with the FLAG epitope) and pCR-FLAG-p50DNLS (nuclear localization signal polypeptide-deficient p50 with the FLAG epitope) constructs were kind gifts from Dr Gourisankar Ghosh (Department of Chemistry and Biochemistry, University of California, San Diego, USA) (Chen et al., 1998) . The vectors encoding the kinase-inactive HA-AktK179M (DN-Akt) and constitutively active Akt HA-mD4-129Akt (CA-Akt) were kind gifts from Dr Michael E Greenberg and Dr Sandeep R Datta (Children's Hospital and Department of Neurobiology, Harvard Medical School, Boston, USA) (Datta et al., 1997) .
Stretch PCR assay
Caov-3 cells were treated with E 2 for various times and cell pellets were collected. For quantitative analyses of telomerase activity, stretch PCR assays were performed using the Telochaser system, according to the manufacturer's protocol (Toyobo, Tokyo, Japan) as described previously (Kyo et al., 1999c) . Briefly, we resuspended the cell pellets in cell lysis buffer so that an aliquot of 20 ml corresponded to 25000 cells. After incubation for 60 min at 371C, the DNA product was isolated and 26 cycles of PCR amplification were performed at 951C for 30 s, at 681C for 30 s and at 721C for 45 s. The PCR products were electrophoresed on a 7% polyacrylamide gel and visualized with SYBR Green I Nucleic Acid Gel Stain (FMC BioProducts, Rockland, ME, USA). To monitor the efficacy of PCR amplification, 10 ng of internal control from phage DNA sequence (Toyobo) together with 50 pmol of specific primers (Toyobo) were added to the PCR mixture per reaction.
RT-PCR analysis
Total cellular RNA was isolated using Tri-Reagent (Molecular Research Center, Inc.) (Chomczynski and Sacchi, 1987) . The expression of hTERT mRNA and GAPDH mRNA were analysed by semiquantitative RT-PCR amplification as described previously (Meyerson et al., 1997; Taniguchi et al., 1999; Yeilding et al., 1996) . Briefly, hTERT mRNAs were amplified using the primer pairs: 5 0 -CGGAAGAGTGTCTG-GAGCAA-3 0 and 5 0 -GGATGAAGCGGAGTCTGGA-3 0 . cDNA was synthesized from 1 mg of RNA using an RNA PCR kit version 2 (TaKaRa, Ohtsu, Japan) with random primers. Serially diluted cDNA reverse-transcribed from 1 mg of RNA was first amplified by RT-PCR to generate standard curves. The correlation between band intensity and dose of cDNA template was linear under the conditions described below. Typically, 2 ml aliquots of the reverse-transcribed cDNA were amplified by 28 cycles of PCR in 50 ml of 1 Â buffer (10 mM Tris-HCl (pH 8.3), 2.5 mM MgCl 2 , and 50 mM KCl) containing 1 mM each dATP, dCTP, dGTP, and dTTP, 2.5 U of Taq DNA polymerase (TaKaRa), and each specific primer at 0.2 mM. Each cycle consisted of denaturation at 941C for 30 s, annealing at 601C for 30 s, and extension at 721C for 45 s. PCR products were resolved by electrophoresis in a 1% agarose gel. The efficiency of cDNA synthesis from each sample was estimated by PCR with GAPDH-specific primers as described previously (Nakayama et al., 1998) .
Luciferase assay
Plasmids pGL3-3328, pGL3-2000, pGL3-1175, pGL3-82, and pGL3 þ 19, containing full-length or 5 0 -deleted hTERT promoters, and pGL3-ERE-P and pGL3-Promoter vector were constructed as described previously (Kyo et al., 1999a, b) . These reporter plasmids were transiently transfected for 24 h using LipofectAMINE Plus (Life Technologies, Gaithersburg, MD, USA), according to the manufacturer's protocol. To examine the effect of Akt on activation of hTERT promoter, pcDNA vector, CA-Akt, or DN-Akt was cotransfected with pGL3-3328. Cells were harvested and subjected to luciferase assays using the Luciferase Assay System (Promega, WI, USA). A plasmid expressing the bacterial b-galactosidase gene was also cotransfected in each experiment to serve as an internal control for transfection efficiency.
Proliferation assays
Caov-3 cells were plated in multiple 96-well cluster dishes in 100 ml of phenol red-free DMEM containing 1% dextrancoated, charcoal-treated fetal calf serum. After 24 h, the cells attached to the dishes, and then E 2 was added at final 10 nM of vehicle with or without pretreatment of 10 mM LY294002. These additions were repeated every 24 h for 4 days. Every day, the number of surviving cells was determined by determination of A 590 nm of the dissolved formazan product after addition of MTS for 1 h as described by the manufacturer (Promega). All experiments were carried out in quadruplicate and the viability is expressed as the ratio of the number of viable cells compared to that with vehicle.
Western blot analysis
Cells were incubated in phenol red-free DMEM without serum for 16 h and then treated with various agents. They were then lysed in ice-cold HNTG buffer (50 mM HEPES, pH 7.5, 150 mM EDTA, 10 mM sodium pyrophosphate, 100 mM sodium orthovanadate, 100 mM sodium fluoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride) (Ohmichi et al., 1994) . Equal amounts of proteins were separated by SDSpolyacrylamide gel electrophoresis (PAGE) and transferred to nitrocellulose membranes. Western blot analyses were performed with various specific primary antibodies. For detection of phosphorylated hTERT or association of hTERT with NFkB p65, cell lysates were prepared using HNTG buffer. Lysates were immunoprecipitated with anti-hTERT antibody. Immune complexes were electrophoresed, and analysed by immunoblotting with anti-phospho-Akt substrate antibody, anti-hTERT antibody, or anti-NFkB p65 antibody. The immunoblots were visualized with horseradish peroxidase-coupled goat anti-rabbit or anti-mouse immunoglobulin by using the enhanced chemiluminescence Western blotting system.
Assay of Akt kinase activity
Lysates were incubated with immobilized anti-Akt antibody crosslinked to agarose hydrazide beads. After Akt was selectively immunoprecipitated from the lysates, the immunoprecipitated products were resuspended in 40 ml of kinase assay buffer containing 200 mM ATP and 1 mg of GSK-3a fusion protein. The kinase reaction was allowed to proceed at 301C for 30 min and stopped by the addition of Laemmli SDS sample buffer (Mabuchi et al., 2002) . Reaction products were resolved by 15% SDS-PAGE followed by Western blotting with an anti-phospho-GSK-3a/b antibody as described previously (Hisamoto et al., 2001a, b) .
In vitro hTERT-14-3-3y binding assay Caov-3 cells were transfected with pCR3 vector or pCR3-hTERT-HA (hTERT-HA) for 24 h using LipofectAMINE Plus according to the manufacturer's protocol. Cells were treated with various agents and then harvested. For the hTERT-14-3-3y binding, total lysates from the Caov-3 cells were prepared with HNTG lysis buffer. Portions of the lysates were preincubated with GST beads and the resulting supernatants were incubated with GST-14-3-3y fusion protein prepared as described previously (Seimiya et al., 2000) . The beads were washed with the lysis buffer and subjected to SDS-PAGE and transferred to nitrocellulose membranes. The specific signals were detected by Western blot analysis, with anti-HA antibody as the primary antibody.
Fluorescence microscopy
Caov-3 cells were grown on glass coverslips in six-well dishes. The cells were transfected with pCR3-hTERT-HA plasmids for 24 h. Then, cells were incubated with or without 10 mM LY294002 for 15 min prior to be treated with or without 10 nM E 2 for 1 h. The cells were fixed with 10% formalin for 10 min, permeabilized with 0.5% Triton X-100 for 5 min, and blocked with 3% bovine serum albumin for 1 h. Anti-HA antibody and Alexa Fluor secondary antibodies were used at 2 mg/ml in blocking solution, and samples were mounted on glass slides with Vectashield (Vector Laboratories). The cells were examined using confocal fluorescence microscopy.
Statistics
Statistical analysis was performed by Student's t-test, and Po0.01 was considered significant. Data are expressed as the mean 7s.e.
